News

Article

SCOPE 2023: Intersection of Healthcare and Clinical Trials

Author(s):

Andy Studna, Senior Editor

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures speaks about how healthcare and clinical trials can work together using technology to accelerate them and bring therapies to patients faster.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
August 15th 2025

2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research

Don Tracy, Associate Editor
Credit: Crystal light | stock.adobe.com. Stomach cancer, gastric cancer, symptoms, stages, treatment, 3d illustration
August 15th 2025

Phase III MATTERHORN Trial Shows Imfinzi Combo Significantly Improves Event-Free Survival in Resectable Gastric and GEJ Cancers

Davy James
© iDoPixBox - © iDoPixBox - stock.adobe.com
August 15th 2025

Tecentriq and Zepzelca Combo Demonstrates Significant Survival Benefit in Phase III Study for Extensive-Stage Small Cell Lung Cancer

Andy Studna, Senior Editor
Credit: Sebastian Kaulitzki | stock.adobe.com
August 15th 2025

Phase III BREAKWATER Trial Shows Braftovi-Based Regimen Improves Survival in BRAF V600E-Mutant Metastatic Colorectal Cancer

Davy James
© Crystal light - © Crystal light - stock.adobe.com.
August 15th 2025

AstraZeneca and Daiichi Sankyo Share Positive Data From Phase III DESTINY-Breast09 Trial of Enhertu Plus Pertuzumab

Andy Studna, Senior Editor
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
August 15th 2025

SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.